Unknown

Dataset Information

0

The importance of antiandrogen in prostate cancer treatment.

ABSTRACT:

SUBMITTER: Lanz C 

PROVIDER: S-EPMC6976485 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The importance of antiandrogen in prostate cancer treatment.

Lanz Camille C   Bennamoun Mostefa M   Macek Petr P   Cathelineau Xavier X   Sanchez-Salas Rafael R  

Annals of translational medicine 20191201 Suppl 8

Similar Datasets

Unknown Proteomic profiling of prostate cancer reveals molecular signatures under antiandrogen treatment.
| S-EPMC11202386 | biostudies-literature
Unknown Development of a second-generation antiandrogen for treatment of advanced prostate cancer.
| S-EPMC2981508 | biostudies-literature
Unknown Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer.
| S-EPMC3762760 | biostudies-literature
Unknown Rational Second-Generation Antiandrogen Use in Prostate Cancer.
| S-EPMC8895732 | biostudies-literature
Unknown Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells.
| S-EPMC3434689 | biostudies-literature
Unknown Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade.
| S-EPMC5593544 | biostudies-literature
Unknown Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
| S-EPMC5444881 | biostudies-literature
Unknown Selectively targeting prostate cancer with antiandrogen equipped histone deacetylase inhibitors.
| S-EPMC3836611 | biostudies-literature
Unknown Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.
| S-EPMC7472556 | biostudies-literature
Unknown Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment.
| S-EPMC10709144 | biostudies-literature